F8 and hemophilia A: Inhibitors develop in approximately one-third of previously untreated patients (PUPs) with severe haemophilia A (i.e., patients with residual FVIII levels below 1 IU/dl), usually within the first 10–15 days of treatment with replacement factor concentrates [1].